MICA Biosystems. Providing Disruptive Nanobiotechnology Platforms
MICA Biosystems uses cutting edge, first-in-class nanobiotechnlogy to enable researchers around the world to push further this frontier of science and medicine, truly unlocking the potential of mechanic ion-channel activation. We have developed a pioneering biomagnetic technology designed to remotely deliver, directed mechanical stimuli to individual cells within culture or within the body.
Recently, the company was recognised in the Global Health & Pharma Biotechnology Awards 2022 for its groundbreaking work, and bestowed with the title of Stem Cell Therapy Innovators of the Year in the UK.
MICA Biosystems constitutes three platforms, each developed from our patented nanotechnology research.
"Our aim isn't purely to take our technology to clinic- we want to reinvigorate excitement around the endless potential for stem cells to revolutionise healthcare."
Dr. Michal Zurawski